Mike Rice, BioLife Solutions President and CEO, commented on the announcement by stating, "HemaCare offers best-in-class bioresearch products derived from the most robust and highest quality apheresis collections. We're glad to partner with them to enable a new product option for their customers. We look forward to additional collaborative research that we believe will generate even more data supporting the value proposition of our proprietary biopreservation media products."
More information can be found here: http://www.hemacare.com/biopreservation_media.asp
About HemaCare HemaCare Corporation is a blood services company serving healthcare providers and the scientific community for over 35 years. HemaCare and its subsidiary, Coral Blood Services, perform therapeutic apheresis services, provide human-derived biological products, and support the use of cellular therapies with apheresis collections. The Company was founded in 1978 and is based in Van Nuys, California. The Company assists the scientific community by providing researchers with the human primary cells, blood components, and tissue they need to advance research. All cellular products and blood components are collected from IRB consented normal donors and patients derived from the following tissues including peripheral blood, mobilized, peripheral blood, bone marrow, and umbilical cord blood. For more information please visit www.hemacare.com.
About BioLife SolutionsBioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions for cells, tissues, and organs. The Company's
|SOURCE BioLife Solutions, Inc.|
Copyright©2012 PR Newswire.
All rights reserved